A government-industry joint report has predicted that India’s emerging biotechnology will become a $100 billion giant from its current $4 billion level by the year 2025. The 2025 industry revenue number has been extrapolated from the 2012 BioSpectrum-ABLE Biotech Industry Survey, which revealed that the sector had a compounded annual growth rate (CAGR) of 24% since 2003. With more support from the government favourable policies, the industry could grow at a CAGR of 30 percent or more in the next decade. This will nudge it past the $100 billion mark by 2025, predicts the report.